FDA Inspection
Qualtex LaboratoriesQualtex Laboratories – FDA Inspection, Sep 21, 2017
Record Details
This FDA Inspection record concerns Qualtex Laboratories, with an inspection on September 21, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 5fde6b0c-940d-43c3-84dc-688a60c4863e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1028892
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Qualtex Laboratories
12| Date | Classification | Office | Project area |
|---|---|---|---|
| September 27, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 27, 2020 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 27, 2020 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 15, 2017 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 20, 2015 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Qualtex Laboratories
- FDA Inspection 1251335 - 2024-09-27
- FDA Inspection 1122019 - 2020-02-27
- FDA Inspection 1122001 - 2020-02-27
- FDA Inspection 1025875 - 2017-09-15
- FDA Inspection 939930 - 2015-08-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.